Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry After a Meal Tolerance Test
Overview
Authors
Affiliations
Background: Proglucagon-derived peptides (PGDPs), which include glucagon-like peptide (GLP)-1, glucagon, and oxyntomodulin, are key regulators of glucose homeostasis and satiety. These peptide hormones are typically measured with immuno-based assays (e.g., ELISA, RIA), which often suffer from issues of selectivity.
Methods: We developed a multiplexed assay for measuring PGDPs including GLP-1 (7-36) amide, GLP-1 (9-36) amide, glucagon, and oxyntomodulin by mass spectrometry and used this assay to examine the effect of a meal tolerance test on circulating concentrations of these hormones. Participants fasted overnight and were either given a meal (n = 8) or continued to fast (n = 4), with multiple blood collections over the course of 3 h. Plasma samples were analyzed by microflow immunoaffinity (IA)-LC-MS/MS with an isotope dilution strategy.
Results: Assay performance characteristics were examined and established during analytical validation for all peptides. Intra- and interassay imprecision were found to be 2.2%-10.7% and 6.8%-22.5%, respectively. Spike recovery was >76%, and dilution linearity was established up to a 16-fold dilution. Immediately after the meal tolerance test, GLP-1 and oxyntomodulin concentrations increased and had an almost identical temporal relationship, and glucagon concentrations increased with a slight delay.
Conclusions: IA-LC-MS/MS was used for the simultaneous and selective measurement of PGDPs. This work includes the first indication of the physiological concentrations and modulation of oxyntomodulin after a meal.
Ackermann B Bioanalysis. 2024; 17(2):79-82.
PMID: 39466131 PMC: 11801340. DOI: 10.1080/17576180.2024.2415763.
Jones B, Shao J, Sanghvi M, Ayala A, Luo R, Wang J Bioanalysis. 2024; 16(14):711-720.
PMID: 38940423 PMC: 11389734. DOI: 10.1080/17576180.2024.2360358.
Exploring the Potential of Bioactive Peptides: From Natural Sources to Therapeutics.
Purohit K, Reddy N, Sunna A Int J Mol Sci. 2024; 25(3).
PMID: 38338676 PMC: 10855437. DOI: 10.3390/ijms25031391.
Takahata Y, Hara M, Nishino K, Kawakami T Mass Spectrom (Tokyo). 2023; 12(1):A0122.
PMID: 37260735 PMC: 10227195. DOI: 10.5702/massspectrometry.A0122.
Kowalka A, Alexiadou K, Cuenco J, Clarke R, Minnion J, Williams E Clin Endocrinol (Oxf). 2022; 99(3):272-284.
PMID: 36345253 PMC: 10952770. DOI: 10.1111/cen.14846.